Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, T. C.
Right arrow Articles by Uhrich, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, T. C.
Right arrow Articles by Uhrich, S. B.

Radiology, Vol 207, 215-222, Copyright © 1998 by Radiological Society of North America

ARTICLES

Frontal lobe shortening in second-trimester fetuses with trisomy 21: usefulness as a US marker

TC Winter, JA Reichman, JA Luna, EY Cheng, AM Doll, CA Komarniski, HV Nghiem, UP Schmiedl, LE Shields and SB Uhrich
Department of Radiology, University of Washington Medical Center, Seattle, WA 98195-7115, USA.

PURPOSE: To determine whether the frontal lobe is disproportionately smaller than normal in second-trimester fetuses with Down syndrome by using prenatal ultrasonographic (US) measurements of the frontothalamic distance (FTD). MATERIALS AND METHODS: The FTD, measured from the inner table of the frontal bone to the posterior margin of the thalamus, was measured in 43 fetuses (mean gestational age, 17.2 weeks +/- 1.3 [standard deviation]; range, 15.0-20.4 weeks) with chromosomally proved trisomy 21 and in 160 chromosomally normal fetuses (mean gestational age, 17.1 weeks +/- 1.5; range, 14.5-22.5 weeks). Other cranial biometric ratios also were calculated. RESULTS: The FTD was best predicted from the estimated gestational age (EGA) in the euploid population with the quadratic equation FTD = -0.0120 x EGA2 + 0.6917 x EGA - 5.2349 (R2 = .731) or from the biparietal diameter (BPD) with the linear equation FTD = 0.6837 x BPD + 0.5525 (R2 = .731). If an observed- to-expected ratio of 0.84 is used as a cutoff sign to screen for trisomy 21, a sensitivity of 16%, specificity of 97%, odds ratio of 6.03 (95% confidence interval, 1.81, 20.1), and relative risk of 5.98 are achieved. CONCLUSION: The frontal lobe is statistically significantly smaller in fetuses with trisomy 21. US measurement of the FTD may prove to be a useful adjunctive screening tool if used with other markers for Down syndrome.


This article has been cited by other articles:


Home page
 RadiologyHome page
T. C. Winter, A. M. Anderson, E. Y. Cheng, C. A. Komarniski, V. L. Souter, S. B. Uhrich, and D. A. Nyberg
Echogenic Intracardiac Focus in 2nd-Trimester Fetuses with Trisomy 21: Usefulness as a US Marker
Radiology, August 1, 2000; 216(2): 450 - 456.
[Abstract] [Full Text]

Home page
 RadiologyHome page
T. C. Winter, S. B. Uhrich, V. L. Souter, and D. A. Nyberg
The "Genetic Sonogram": Comparison of the Index Scoring System with the Age-adjusted US Risk Assessment
Radiology, June 1, 2000; 215(3): 775 - 782.
[Abstract] [Full Text]

Home page
 RadiologyHome page
T. C. Winter, A. A. Ostrovsky, C. A. Komarniski, and S. B. Uhrich
Cerebellar and Frontal Lobe Hypoplasia in Fetuses with Trisomy 21: Usefulness as Combined US Markers
Radiology, February 1, 2000; 214(2): 533 - 538.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1998 by the Radiological Society of North America.